LIPA and atherosclerosis: In addition to utilizing recombinant LAL to treat complete and partial LAL deficiency, we are now learning much more about the role of LIPA expression as a predictor of cardiovascular risk, and the likelihood that naturally occurring low levels of LIPA expression predict the formation of SMC foam cells, the proposed primary source of foam cells in atherosclerosis.